Page last updated: 2024-10-29

iopromide and Heritable Pulmonary Arterial Hypertension

iopromide has been researched along with Heritable Pulmonary Arterial Hypertension in 1 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pienn, M1
Kovacs, G1
Tscherner, M1
Johnson, TR1
Kullnig, P1
Stollberger, R1
Olschewski, A1
Olschewski, H1
Bálint, Z1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography - Pilot Study[NCT01607489]25 participants (Actual)Interventional2011-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for iopromide and Heritable Pulmonary Arterial Hypertension

ArticleYear
Determination of cardiac output with dynamic contrast-enhanced computed tomography.
    The international journal of cardiovascular imaging, 2013, Volume: 29, Issue:8

    Topics: Adult; Aged; Aorta; Aortography; Cardiac Catheterization; Cardiac Output; Contrast Media; Familial P

2013